Business Context and Reporting Period
Company: Photronics, Inc. (PLAB)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter ended May 4, 2025 (Q2 FY25) and six months ended May 4, 2025.
Business Overview: Photronics is a leading manufacturer of photomasks used in the fabrication of integrated circuits (ICs) and flat panel displays (FPDs). The company operates 11 manufacturing facilities globally, including a significant joint venture in China (PDMCX) with Dai Nippon Printing Co., Ltd. (DNP).
Key Financial Metrics
| Metric (in thousands) | Q2 FY25 | Q2 FY24 | YTD FY25 | YTD FY24 |
|---|---|---|---|---|
| Revenue | $210,992 | $217,000 | $423,130 | $433,334 |
| Gross Profit | $77,906 | $79,251 | $153,441 | $158,506 |
| Gross Margin | 36.9% | 36.5% | 36.3% | 36.6% |
| Operating Income | $55,717 | $56,052 | $107,894 | $113,542 |
| Net Income (Total) | $24,217 | $56,372 | $82,474 | $95,454 |
| Net Income Attributable to Photronics | $8,861 | $36,251 | $51,712 | $62,431 |
| Diluted EPS (Photronics) | $0.15 | $0.58 | $0.84 | $1.00 |
| Cash and Cash Equivalents | $530,708 | $493,905 | $530,708 | $493,905 |
| Total Debt | $30 | $17,997 | $30 | $17,997 |
Note: Debt consists primarily of finance leases. The company repaid significant lease obligations in the period.
Material Changes vs. Prior Period
- Revenue Decline: Q2 FY25 revenue decreased 2.8% year-over-year (YoY) to $211.0 million, driven by a 3.1% decline in IC revenue (specifically mainstream products) and a 1.7% decline in FPD revenue. Year-to-date (YTD) revenue fell 2.4%.
- Significant FX Impact: Net income attributable to shareholders dropped significantly (75.5% YoY in Q2) primarily due to a $31.1 million foreign currency transaction loss in Q2 FY25, compared to a $14.8 million gain in Q2 FY24. This was driven by unfavorable movements in the New Taiwan dollar and South Korean won against the U.S. dollar.
- Margin Expansion: Despite revenue declines, gross margin improved to 36.9% in Q2 FY25 (up 40 basis points YoY) due to reduced labor, benefits, and material costs.
- Debt Reduction: Total debt decreased from $18.0 million to $30,000 as the company exercised early buyout options on high-end lithography and inspection tool finance leases.
- Share Repurchases: The company repurchased 3.6 million shares for $72.1 million in Q2 FY25 and 3.8 million shares for $76.7 million YTD, significantly reducing outstanding shares.
Guidance, Outlook, and Risks
- Guidance: Specific financial guidance for the full fiscal year is not included in this filing text; investors are directed to the Q2 FY25 earnings press release and conference call.
- Capital Expenditures: Management estimates FY25 capital expenditures will be approximately $200 million, focused on high-end and mainstream capacity in Asia and the U.S. Outstanding commitments are $164.8 million.
- Joint Venture (PDMCX): The company consolidates its 50.01% interest in the Xiamen joint venture. DNP (the 49.99% partner) has the right to put its interest to Photronics or purchase Photronics' interest at net book value if ownership falls below 20% for six months. No intent to exercise this right has been indicated.
- Risk Factors:
- Trade Policy: New tariffs announced in Q2 FY25 on imports from China, Taiwan, South Korea, Japan, and the EU pose risks to supply chain costs and demand.
- Foreign Currency: Significant exposure to the South Korean won, Chinese yuan, and New Taiwan dollar. A 10% adverse movement could result in a $71.3 million pre-tax loss.
- Industry Cyclicality: Demand is tied to semiconductor design activity rather than end-product sales volumes, making the business susceptible to industry downturns.
Investor Verification Checklist
- FX Sensitivity: Verify the magnitude of the $31.1 million foreign currency loss and its impact on the effective tax rate and non-GAAP earnings reconciliation.
- Revenue Mix: Confirm the specific drivers behind the decline in "Mainstream" IC revenue versus the stability of "High-end" IC revenue.
- Capital Commitments: Review the $164.8 million in outstanding capital commitments and the timeline for the estimated $152.3 million to be funded in the next 12 months.
- Share Count: Note the reduction in weighted-average shares outstanding due to the aggressive $76.7 million share repurchase program YTD.
- Joint Venture Status: Monitor the PDMCX joint venture for any potential exercise of the put/call option by DNP, which could alter the company's asset base and noncontrolling interest structure.